Showing 1 - 20 results of 30 for search 'Alessandro Isidori', query time: 0.06s Refine Results
  1. 1
    Current Challenges in Hematology: Awareness, Prevention, Equity

    Current Challenges in Hematology: Awareness, Prevention, Equity by Dominic Kaye, Alessandro Isidori

    Published 2021-04-01
    Get full text
    Article
  2. 2
    Editorial: The Biological Landscape of Immunotherapy in AML

    Editorial: The Biological Landscape of Immunotherapy in AML by Alessandro Isidori, Naval Daver, Antonio Curti

    Published 2021-04-01
    Get full text
    Article
  3. 3
    Editorial: COVID-19 and hematological malignancies: Volume II

    Editorial: COVID-19 and hematological malignancies: Volume II by Lindsay Wilde, Adam Binder, Claudio Cerchione, Alessandro Isidori

    Published 2022-10-01
    Get full text
    Article
  4. 4
    AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS

    AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS by Giuseppe Visani, Paola Picardi, Patrizia Tosi, Alessandro Isidori

    Published 2012-11-01
    Get full text
    Article
  5. 5
    Editorial: Immunobiology and immunotherapeutics in myelodysplastic syndrome and acute myeloid leukemia

    Editorial: Immunobiology and immunotherapeutics in myelodysplastic syndrome and acute myeloid leukemia by Shyam A. Patel, Alessandro Isidori, Claudio Cerchione, Anna Aureli

    Published 2024-10-01
    Get full text
    Article
  6. 6
    BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia

    BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia by Federica Loscocco, Giuseppe Visani, Sara Galimberti, Antonio Curti, Alessandro Isidori

    Published 2019-09-01
    Get full text
    Article
  7. 7
    Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?

    Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment? by Fabio Guolo, Fabio Guolo, Claudio Cerchione, Chiara Vernarecci, Alessandro Isidori

    Published 2022-09-01
    Get full text
    Article
  8. 8
    Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience

    Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience by Lindsay Wilde, Alessandro Isidori, Gina Keiffer, Neil Palmisiano, Margaret Kasner

    Published 2020-09-01
    Get full text
    Article
  9. 9
    Treatment options for acute myeloid leukemia patients aged <60 years

    Treatment options for acute myeloid leukemia patients aged <60 years by Giuseppe Visani, Martina Chiarucci, Sara Paolasini, Federica Loscocco, Alessandro Isidori

    Published 2022-10-01
    Get full text
    Article
  10. 10
    Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned

    Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned by Alessandro Isidori, Laurence de Leval, Usama Gergis, Pellegrino Musto, Pierluigi Porcu

    Published 2020-08-01
    Get full text
    Article
  11. 11
    Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions

    Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions by Bachar Samra, Marina Konopleva, Alessandro Isidori, Naval Daver, Courtney DiNardo

    Published 2020-11-01
    Get full text
    Article
  12. 12
    The incidence of pleural and pericardial effusion is not higher in patients receiving dasatinib at low doses. (Reply)

    The incidence of pleural and pericardial effusion is not higher in patients receiving dasatinib at low doses. (Reply) by Giuseppe Visani, Massimo Breccia, Enrico Montefusco, Enrica Morra, Valeria Santini, Alessandro Isidori

    Published 2011-04-01
    Get full text
    Article
  13. 13
    Editorial: The management of hematologic malignancies in lower-income countries

    Editorial: The management of hematologic malignancies in lower-income countries by Prasanth Ganesan, Jean El Cheikh, Alessandro Isidori, Sung-Hsin Kuo, Mustafa Saleh, Reena Nair

    Published 2023-05-01
    Get full text
    Article
  14. 14
    Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients

    Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients by Martina Chiarucci, Sara Paolasini, Alessandro Isidori, Barbara Guiducci, Federica Loscocco, Maria Capalbo, Giuseppe Visani

    Published 2021-09-01
    Get full text
    Article
  15. 15
    Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia

    Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia by Darina Ocadlikova, Mariangela Lecciso, Alessandro Isidori, Federica Loscocco, Giuseppe Visani, Sergio Amadori, Michele Cavo, Antonio Curti

    Published 2019-10-01
    Get full text
    Article
  16. 16
    Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase

    Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase by Massimo Breccia, Elisabetta Abruzzese, Alessandra Iurlo, Antonella Gozzini, Alessandro Isidori, Domenica Gangemi, Patrizia Pregno, Giuliana Alimena

    Published 2016-06-01
    Get full text
    Article
  17. 17
    Management of infections for patient treated with ibrutinib in clinical practice

    Management of infections for patient treated with ibrutinib in clinical practice by Claudia Baratè, Ilaria Scortechini, Sara Ciofini, Paola Picardi, Ilaria Angeletti, Federica Loscocco, Alessandro Sanna, Alessandro Isidori, Paolo Sportoletti

    Published 2024-09-01
    Get full text
    Article
  18. 18
    Third party cord blood transplant boosts autologous hematopoiesis in a case of persistent bone marrow aplasia after double transplant failure for β-thalassemia major

    Third party cord blood transplant boosts autologous hematopoiesis in a case of persistent bone marrow aplasia after double transplant failure for β-thalassemia major by Giuseppe Visani, Paola Picardi, Barbara Guiduccu, Claudio Giardini, Moira Lucesole, Sara Barulli, Teresa Ricciardi, Federica Loscocco, Alessandro Isidori

    Published 2013-04-01
    Get full text
    Article
  19. 19
    The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia

    The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia by Marilena Ciciarello, Giulia Corradi, Federica Loscocco, Giuseppe Visani, Federica Monaco, Michele Cavo, Michele Cavo, Antonio Curti, Alessandro Isidori

    Published 2019-10-01
    Get full text
    Article
  20. 20
    PB2379: SPECIFIC ALTERATIONS IN MEMBRANE LIPID LEVELS AS POTENTIAL BIOMARKERS IN DLBCL PATIENTS

    PB2379: SPECIFIC ALTERATIONS IN MEMBRANE LIPID LEVELS AS POTENTIAL BIOMARKERS IN DLBCL PATIENTS by Federica Loscocco, Federica DI Nolfo, Alessandro Isidori, Anna Sansone, Marino Brunori, Martina Chiarucci, Monica Calandrelli, Giuseppe Visani, Carla Ferreri

    Published 2023-08-01
    Get full text
    Article

Search Tools: